CA2780703A1 - Drug combination with theobromine and its use in therapy - Google Patents

Drug combination with theobromine and its use in therapy Download PDF

Info

Publication number
CA2780703A1
CA2780703A1 CA2780703A CA2780703A CA2780703A1 CA 2780703 A1 CA2780703 A1 CA 2780703A1 CA 2780703 A CA2780703 A CA 2780703A CA 2780703 A CA2780703 A CA 2780703A CA 2780703 A1 CA2780703 A1 CA 2780703A1
Authority
CA
Canada
Prior art keywords
theobromine
therapy
cough
agent
dextromethorphan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2780703A
Other languages
English (en)
French (fr)
Inventor
John Brew
Robin Mark Bannister
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Infirst Healthcare Ltd
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41509324&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2780703(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of CA2780703A1 publication Critical patent/CA2780703A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2780703A 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy Abandoned CA2780703A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0919889.6A GB0919889D0 (en) 2009-11-13 2009-11-13 Drug composition and its use in therapy
GB0919889.6 2009-11-13
PCT/GB2010/051895 WO2011058373A2 (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy

Publications (1)

Publication Number Publication Date
CA2780703A1 true CA2780703A1 (en) 2011-05-19

Family

ID=41509324

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2780703A Abandoned CA2780703A1 (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy

Country Status (17)

Country Link
EP (1) EP2498777A2 (enExample)
JP (2) JP2013510841A (enExample)
CN (1) CN102753174A (enExample)
AU (1) AU2010317667B2 (enExample)
BR (1) BR112012011227A2 (enExample)
CA (1) CA2780703A1 (enExample)
CO (1) CO6551744A2 (enExample)
GB (1) GB0919889D0 (enExample)
IL (1) IL219768A0 (enExample)
MX (1) MX2012005532A (enExample)
NZ (1) NZ599949A (enExample)
PE (1) PE20130147A1 (enExample)
PH (1) PH12012501369A1 (enExample)
RU (1) RU2519086C2 (enExample)
UA (1) UA108993C2 (enExample)
WO (1) WO2011058373A2 (enExample)
ZA (1) ZA201204248B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
WO2017117347A1 (en) * 2015-12-30 2017-07-06 Markovitz M D Paul Method of treating schizophrenia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834479A (en) * 1993-03-05 1998-11-10 Mayer; David J. Method and composition for alleviating pain
CA2272640C (en) * 1996-11-25 2003-07-08 The Procter & Gamble Company Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
HUP9700654A2 (hu) * 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
US20030206942A1 (en) * 1998-09-25 2003-11-06 Neema Kulkarni Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent
US6207674B1 (en) * 1999-12-22 2001-03-27 Richard A. Smith Dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants
WO2004105705A1 (en) * 2003-05-29 2004-12-09 Unilever Plc Hair treatment compositions
US20060153926A1 (en) * 2005-01-10 2006-07-13 Bascom Charles C Compositions, products and methods for controlling weight in a mammal
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
US20080176955A1 (en) * 2007-01-16 2008-07-24 Victory Pharma, Inc. Combined administration of benzonatate and guaifenesin

Also Published As

Publication number Publication date
JP2013510841A (ja) 2013-03-28
RU2519086C2 (ru) 2014-06-10
JP2016128439A (ja) 2016-07-14
CO6551744A2 (es) 2012-10-31
EP2498777A2 (en) 2012-09-19
GB0919889D0 (en) 2009-12-30
NZ599949A (en) 2013-08-30
ZA201204248B (en) 2013-02-27
WO2011058373A2 (en) 2011-05-19
PE20130147A1 (es) 2013-03-13
BR112012011227A2 (pt) 2017-06-13
IL219768A0 (en) 2012-07-31
WO2011058373A3 (en) 2011-07-07
RU2012124038A (ru) 2013-12-20
UA108993C2 (en) 2015-07-10
AU2010317667B2 (en) 2014-05-29
CN102753174A (zh) 2012-10-24
JP6118919B2 (ja) 2017-04-19
MX2012005532A (es) 2012-09-28
PH12012501369A1 (en) 2012-10-22
AU2010317667A1 (en) 2012-06-07

Similar Documents

Publication Publication Date Title
JP6118919B2 (ja) テオブロミンとの薬物組み合わせおよび治療におけるその使用
JP6078605B2 (ja) テオブロミンと抗ヒスタミン剤との治療用組み合わせ剤
AU2011294905B2 (en) Theobromine in combination with an expectorant or a mucolytic for use in therapy
CA2784214C (en) Combination of theobromine with a decongestant and its use for the treatment of cough
CA2780704C (en) Drug combination with theobromine and its use in therapy
AU2015201844B2 (en) Therapeutic Combinations of Theobromine and an Antihistamine
AU2015200654B2 (en) Combination of theobromine with a decongestant and its use for the treatment of cough
AU2015201845B2 (en) Drug combination with theobromine and its use in therapy
AU2015200651B2 (en) Theobromine in combination with an expectorant or a mucolytic for use in therapy

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20151110

FZDE Discontinued

Effective date: 20191113